| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ryan Arthur F serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 490 sells. Those positions are worth an estimated $11.2M at current prices.
Historically, Ryan Arthur F's trades have earned a middling insider score of 54/100 across 38 rated trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of -2.1%.
The biggest single holding is REGN (~$11.2M) as Director. The recent filings there lean toward selling, a net 14,196 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell10b5-1 | 90 | $804.87 | $72,437.99 | -0.5% | -8.0% | +10.4% | |
| Apr 3, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell10b5-1 | 100 | $819.31 | $81,931.21 | -0.5% | -13.1% | +15.6% | |
| Mar 1, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $762.50 | $76,249.72 | -0.5% | -5.4% | +25.4% | |
| Feb 1, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $756.13 | $75,613.49 | -0.5% | +5.3% | +26.4% | |
| Jan 3, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $726.29 | $72,628.79 | -0.5% | +14.7% | +27.4% | |
| Dec 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $758.17 | $75,817.49 | -0.5% | +1.2% | +7.0% | |
| Nov 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $755.89 | $75,588.55 | -0.5% | -3.1% | +4.1% | |
| Oct 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $726.54 | $72,654.30 | -0.5% | -2.0% | +10.0% | |
| Sep 6, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $582.37 | $58,236.73 | -0.5% | +31.6% | +42.6% | |
| Aug 4, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 10,453 | $621.29 | $6,494,318.79 | -34.7% | +20.4% | +24.6% |